{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:59:58Z","timestamp":1792645198452,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.arcmed.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T08:31:49Z","timestamp":1533889909000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats"],"prefix":"10.1016","volume":"49","author":[{"given":"Roshni","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurang","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2018.08.001_bib1","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod Reprod"},{"key":"10.1016\/j.arcmed.2018.08.001_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2265.2010.03956.x","article-title":"PCOS Forum: research in polycystic ovary syndrome tod and tomorrow","volume":"74","author":"Pasquali","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2018.08.001_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9378(98)70238-8","article-title":"Polycystic ovary syndrome: Symptomatology, pathophysiology, and epidemiology","volume":"179","author":"Guzick","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1210\/jcem-72-6-1308","article-title":"Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin resistant female","volume":"72","author":"Declue","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib6","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","article-title":"Insulin enhancement of luteinizing hormone and follicle-stimulating sormone release by cultured pituitary cells","volume":"108","author":"Adashi","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2018.08.001_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.steroids.2011.12.007","article-title":"Neuroendocrine dysfunction in polycystic ovary syndrome","volume":"77","author":"Burt Solorzano","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.arcmed.2018.08.001_bib9","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2018.08.001_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.arcmed.2018.08.001_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclicity after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Vel\u00e1zquez","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib12","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09513590701492689","article-title":"Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations","volume":"23","author":"Koo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.fertnstert.2010.06.058","article-title":"Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome\u202f: a prospective randomized study","volume":"95","author":"Naka","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arcmed.2018.08.001_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s004040100176","article-title":"Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome","volume":"265","author":"Batukan","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.arcmed.2018.08.001_bib16","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2011-3061","article-title":"Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): A multicenter, double-Blind, placebo-controlled randomized trial","volume":"97","author":"Morin-papunen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.fertnstert.2007.01.117","article-title":"Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome","volume":"90","author":"Ota","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arcmed.2018.08.001_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0015-0282(16)58266-1","article-title":"Can metformin reduce insulin resistance in polycystic ovary syndrome?","volume":"65","author":"Acbay","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arcmed.2018.08.001_bib19","first-page":"2057","article-title":"Effects of diet and metformin administration on sex hormone binding globulin, androgens and insulin in hirsute and obese women","volume":"80","author":"Crave","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib20","first-page":"524","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib21","first-page":"1","article-title":"Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"0","author":"Patel","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.arcmed.2018.08.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/381231","article-title":"Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"2014","author":"Zhuo","year":"2014","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.arcmed.2018.08.001_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/humupd\/dms036","article-title":"Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"19","author":"Misso","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.arcmed.2018.08.001_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/09513590.2015.1041906","article-title":"Efficacy of metformin on pregnancy complications in women with polycystic ovary syndrome: a meta-analysis","volume":"31","author":"Feng","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome\u202f: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.arcmed.2018.08.001_bib26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2010.03917.x","article-title":"Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis","volume":"74","author":"Li","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2018.08.001_bib27","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.fertnstert.2012.07.213","article-title":"Metformin treatment prevents the development of endothelial dysfunction in a rat model of polycystic ovary syndrome (PCOS)","volume":"98","author":"Hurliman","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arcmed.2018.08.001_bib28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1210\/en.2014-1765","article-title":"Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model","volume":"156","author":"Di Pietro","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2018.08.001_bib29","series-title":"Metformin treatment decreases ovarian VEGF and angiopoietin1 Levels, improves follicular development and decreases cyst formation in a rat model of polycystic ovary syndrome","author":"Di Pietro","year":"2014"},{"key":"10.1016\/j.arcmed.2018.08.001_bib30","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1093\/humrep\/det341","article-title":"Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats","volume":"2","author":"Zhang","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.arcmed.2018.08.001_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2017.03.023","article-title":"Metformin ameliorates uterine defects in a rat model of polycystic ovary syndrome","volume":"18","author":"Zhang","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arcmed.2018.08.001_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-22-39","article-title":"Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation","volume":"22","author":"Kabiri","year":"2014","journal-title":"DARU J Pharm Sci"},{"key":"10.1016\/j.arcmed.2018.08.001_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","article-title":"Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease","volume":"35","author":"Kafali","year":"2004","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2018.08.001_bib34","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1210\/en.2007-0168","article-title":"A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome","volume":"148","author":"Manneras","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2018.08.001_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/REP-17-0584","article-title":"High fat diet exposure from pre-pubertal age induces PCOS in rats","volume":"155","author":"Patel","year":"2018","journal-title":"Reproduction"},{"key":"10.1016\/j.arcmed.2018.08.001_bib36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.arcmed.2018.08.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1993.tb01744.x","article-title":"The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women","volume":"39","author":"Pasquali","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2018.08.001_bib38","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0975-9476.74090","article-title":"Effect of Aloe barbadensis Mill. formulation on Letrozole induced polycystic ovarian syndrome rat model","volume":"1","author":"Maharjan","year":"2010","journal-title":"J Ayurveda Integr Med"},{"key":"10.1016\/j.arcmed.2018.08.001_bib39","first-page":"323","article-title":"Effects of metformin on weight loss\u202f: potential mechanisms","volume":"21","author":"Malin","year":"2014","journal-title":"Curr Opin"},{"key":"10.1016\/j.arcmed.2018.08.001_bib40","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome","volume":"21","author":"Costello","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.arcmed.2018.08.001_bib41","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"Harborne","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib42","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/humrep\/deg264","article-title":"Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome","volume":"18","author":"Romualdi","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.arcmed.2018.08.001_bib43","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome","volume":"90","author":"Ortega-Gonz\u00e1lez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.arcmed.2018.08.001_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00024677-200201010-00005","article-title":"Potential utility of insulin sensitizers in the treatment of patients with polycystic ovary syndrome","volume":"1","author":"Bayram","year":"2002","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bpobgyn.2004.05.004","article-title":"The pathophysiology of polycystic ovary syndrome: Trying to understand PCOS and its endocrinology","volume":"18","author":"Balen","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4239\/wjd.v2.i3.33","article-title":"Assessing and treating insulin resistance in women with polycystic ovarian syndrome","volume":"2","author":"Traub","year":"2011","journal-title":"World J Diabetes"},{"key":"10.1016\/j.arcmed.2018.08.001_bib48","first-page":"1314","article-title":"Effects of visfatin and metformin on insulin resistance and reproductive endocrine in rats with polycystic ovary syndrome","volume":"34","author":"Zhang","year":"2014","journal-title":"J South Med Univ"},{"key":"10.1016\/j.arcmed.2018.08.001_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.arcmed.2018.08.001_bib50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","volume":"157","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib51","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1210\/jc.2005-0615","article-title":"Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome","volume":"90","author":"Glintborg","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-2003-39056","article-title":"Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome\u202f: A randomized, double-blind and placebo-controlled trial","volume":"35","author":"Chou","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.arcmed.2018.08.001_bib53","first-page":"588","article-title":"Inositol requirement of the gerbil","volume":"104","author":"Hegsted","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/molehr\/7.8.697","article-title":"Gonadotrophin receptor expression on human granulosa cells of low and normal responders to FSH","volume":"7","author":"Thiruppathi","year":"2001","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.arcmed.2018.08.001_bib55","doi-asserted-by":"crossref","first-page":"E1491","DOI":"10.1210\/jc.2013-1865","article-title":"Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: Relevance to polycystic ovary syndrome","volume":"98","author":"Rice","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2018.08.001_bib56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/EJE-12-0655","article-title":"Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome","volume":"168","author":"Panidis","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2018.08.001_bib57","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-132-12-200006200-00010","article-title":"The Importance of diagnosing the polycystic ovary syndrome","volume":"132","author":"Lobo","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arcmed.2018.08.001_bib58","first-page":"90","article-title":"Metformin therapy decreases hyperandrogenism and ovarian volume in women with polycystic ovary syndrome","volume":"36","author":"Sanoee","year":"2011","journal-title":"Iran J Med Sci"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440918304235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440918304235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:46:35Z","timestamp":1759261595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440918304235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0188440918304235"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2018.08.001","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin Sensitizers Modulate GnRH Receptor Expression in PCOS Rats","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}